We recently compiled a list of the 15 AI News Investors Should Not Miss. In this article, we are going to take a look at where GE HealthCare Technologies Inc. (NASDAQ:GEHC) stands against the other AI stocks investors should not miss.
Artificial Intelligence developments are making headlines across various sectors. From high-profile legal battles to groundbreaking advancements in model performance and safety protocols, AI is reshaping the landscape across industries at an unprecedented pace.
READ ALSO: 15 AI News Investors Should Not Miss and 20 Trending AI Stocks on Latest News and Ratings
Before we move on to the breaking news on AI, let’s talk about Morningstar’s recent report. The investment research firm reveals that for the third consecutive year, investors are leaving exchange-traded funds related to specific themes for funds linked to broad stock-market benchmarks “that are hitting record highs”. Despite overall growth in equity ETFs, thematic ETFs have lost $5.8 billion in investor capital in the year 2024. This is greater than $4.8 billion outflows in all of 2023. The reason? Broad market index returns are setting a higher bar for thematic funds this year.
“It’s not that people don’t like the idea of themes any longer, but that a bull market dominated by a handful of megacaps makes it hard for any theme to stand out”.
-Aniket Ullal, ETF analyst at CFRA, a market research firm.
As per Morningstar, thematic ETFs often struggle due to mistimed investments, with investors usually missing out on two-thirds of their returns. Despite some AI-themed funds having strong holdings, higher fees and timing challenges reduce their overall appeal.
“I think that when S&P 500 megacaps stop delivering the way they do today, the focus will shift back to thematic ETFs”.
-Taylor Krystkowiak, investment strategist at Themes ETFs, an investment management firm.
Moreover, while AI remains a key focus in many thematic ETFs, its impact goes far beyond investing. Consider Penguin Random House, the first of the Big Five anglophone trade publishers to amend its copyright information. The publisher has recently added a language to its copyright pages to prohibit the use of those books to train AI. Publishers and AI firms will be increasingly clashing in the future if clear guidelines and processes aren’t kept in place. In a similar endeavor, The New York Times has sent Perplexity AI, an AI-powered research firm, a “cease and desist” notice demanding that it stop using the newspaper’s content for generative AI purposes. The news publisher claims that the way the AI Company uses its material violates copyright law.
In other news, Anthropic, a U.S.-based artificial intelligence public-benefit startup, is now adding a comprehensive update to its safety policy, reinforcing the guardrails of its AI as it becomes more capable. This push to improve AI safety is in stark contrast to competitors such as OpenAI, whose increasing focus on improving capabilities and performance is very likely to threaten safety guidelines in the future. As per McKinsey, 63% of companies consider inaccuracy risk to be relevant. However, only 38% of companies are working to mitigate the risk.
While artificial intelligence may be intimidating, it is equally, if not more, beneficial for mankind. In its latest achievement, AI has helped UCLA researchers develop a deep-learning framework that teaches itself to automatically analyze and diagnose MRIs and other 3D medical images. That too, with the accuracy matching that of medical specialists in a fraction of the time. Another breakthrough from Archetype AI, a physical AI company, is set to significantly change how we understand and interact with the physical world. The model, named Newton, shows the unparalleled capacity to generalize across diverse physical phenomena using only raw sensor measurements as input.
Finally, in our roundup of the latest AI news, the US rules that will ban certain US investments in artificial intelligence in China are under final review, as per a government posting. The rules, requiring US investors to notify the Treasury Department regarding some investments in AI and other stem technologies, come from an executive order signed by President Joe Biden in August 2023. The order aims to keep American investors’ know-how from aiding China’s military. Chipmakers and related companies that may be impacted by the decisions denied responding to Reuters’ requests for comment.
Methodology
For this article, we selected AI stocks by combing through news articles, stock analysis, and press releases. These stocks are also popular among hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
A radiologist in a lab examining a computed tomography scan of a patient.
GE HealthCare Technologies Inc. (NASDAQ:GEHC)
Number of Hedge Fund Holders: 49
GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a leading global medical technology company that provides digital infrastructure, data analytics & decision support tools that help healthcare workers in the diagnosis, treatment, and monitoring of patients. The company incorporates artificial intelligence in many of its products and services.
On Monday, October 21, GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced a new artificial intelligence application to help doctors who diagnose and treat cancer to save time. Known as CareIntellect for Oncology, the AI application will help doctors get up to speed by showing them the data they need on a patient’s history and disease progression. This will help spare them from the headache of digging through records.
The application will also be able to help identify relevant clinical trials that the patients may be eligible for. Previously, doctors had to go through a lengthy procedure involving going through a database of trials, memorizing inclusion and exclusion criteria, and digging through patient records to determine a good fit. CareIntellect for Oncology is expected to be widely available for use to US customers in the year 2025, initially targeting prostate and breast cancers.
The company has also introduced an AI innovation lab, a move designed to accelerate early-concept AI innovations within the company. The AI projects are part of its broader AI and digital strategy, focusing on integrating AI into medical devices, integrating AI into applications, and also using AI to support better outcomes. The company’s investment in cloud technology supports its strategy by providing the computing power needed for large-scale AI development.
“The AI Innovation Lab lifts the curtain on the work we are undertaking at the vanguard of healthcare innovation. At GE HealthCare, we’re not just developing technology—we’re striving to break new ground by exploring novel ways that AI could enable healthcare. For example, through projects like Health Companion, we are evaluating ways to apply agentic AI in order to bring the clinical knowledge and problem-solving insights of a multi-disciplinary medical team to clinicians’ fingertips and help them take action. The pioneering projects we’re showcasing today are just some of the innovations we have underway, enabled by our AI and cloud computing capabilities. We will continue to gather feedback from our customers as we find ways to help them apply AI to their health data and convert information into actionable, care-enhancing strategies”.
– Dr. Taha Kass-Hout, GE HealthCare’s Global Chief Science and Technology Officer.
Overall GEHC ranks 9th on our list of the AI stocks investors shouldn’t miss. While we acknowledge the potential of GEHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than GEHC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.
Disclosure: None. This article is originally published at Insider Monkey.
